Latest Full genome sequencing Stories
SAN DIEGO and ST. LOUIS, Oct. 15, 2012 /PRNewswire/ -- Assay Depot and Rare Genomics Institute have joined together in a unique partnership with 19 life science companies to launch the first Rare Disease Science Challenge: Be HEARD (Helping Empower and Accelerate Research Discoveries). Rare diseases affect over 25 million Americans, yet less than five percent of the 7,000 known rare diseases have any therapy. The hosts and sponsoring organizations are supporting rare disease...
PROVIDENCE, R.I., Oct. 10, 2012 /PRNewswire/ -- Nabsys, Inc., a life sciences company pioneering solid-state, single-molecule positional sequencing for broad applicability in DNA analysis, today announced two additions to its senior management team, Peter Lewis as chief financial officer and Darren Lee as vice president, business development. These appointments are part of the company's transition from a technology development focus to a commercial entity that is manufacturing and...
Connie K. Ho for redOrbit.com – Your Universe Online Technology is changing faster than ever. With the click of a button you can send messages to friends, share photos and watch videos. This rapid speed is also being seen in medical technology. A new study found that doctors can quickly diagnose genetic diseases in babies with a simple blood test, allowing doctors to decode the baby’s complete genome in two days as opposed to the current time frame of at least six weeks. According...
KANSAS CITY, Mo., Oct. 3, 2012 /PRNewswire/ -- Today investigators at Children's Mercy Hospitals and Clinics in Kansas City reported the first use of whole genome information for diagnosing critically ill infants. As reported in Science Translational Medicine, the team describes STAT-Seq®, a whole genome sequencing approach - from blood sample to returning results to a physician - in about 50 hours. Currently, testing even a single gene takes six weeks or more. Speed of...
MOUNTAIN VIEW, Calif., Oct. 3, 2012 /PRNewswire/ -- Genia Technologies, Inc. today announced a collaboration with investigators at Columbia University and Harvard University to develop a nanopore-based sequencing system that will accelerate the use of DNA sequencing in the clinic. The three-way collaboration focuses on the development of a single molecule sequencing system combining Genia's standard complementary metal-oxide semiconductor (CMOS) integrated circuit, Professor George...
The cost of sequencing the entire human genome, or exome – the regions of the genome that are translated into proteins that affect cell behavior – has decreased significantly, to the point where the cost of looking at the majority of a patient's genomic data may be less expensive than undertaking one or two targeted genetic tests. While efficient, the acquisition of this much genetic data – in some cases as many as 1.5 to 2 million variants – creates other challenges. In a paper...
CARLSBAD, Calif., Sept 13, 2012 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced it is now shipping the Ion Proton(TM) System. The platform's speed, ease-of-use and affordability will democratize genome sequencing. For the first time, genome-scale sequencing is accessible to all scientists and medical researchers, enabling an unprecedented wave of innovation in life sciences and the advancement of clinical research. "The Ion Proton System is an...
The Cancer Genetics Laboratory at Baylor College of Medicine now offers the Cancer Exome Sequencing test, which uses next-generation sequencing to identify acquired changes in the DNA of a patient's tumor. "Cancer exome sequencing is poised to change the current paradigm of genetic testing for cancer patients," said Dr. Federico Monzon, director of molecular pathology at the Cancer Genetics Laboratory at BCM. "Rather than testing a single gene or panel of genes, cancer exome sequencing...
Reconstructing the spread of killer diseases such as tuberculosis (TB) from person to person using DNA sequencing quickly identifies the origin and movement of pathogens. This approach is directly informing public health strategies to control infectious disease outbreaks, says a scientist speaking at the Society for General Microbiology's Autumn Conference at the University of Warwick. A team from the British Columbia Centre for Disease Control in Vancouver, Canada used whole-genome...
ORANGE, Calif., Aug. 13, 2012 /PRNewswire/ -- As part of a pilot study designed to advance personalized treatment for children and teens battling recurrent cancer, the Hyundai Cancer Institute at CHOC Children's is the first organization to utilize Illumina's RapidTrack Whole Genome Sequencing (RapidTrack WGS) service for cancer samples. RapidTrack WGS will enable the study to gather whole genome sequencing data in high depth within 14 days, which is the fastest sample-to-data...
